245 related articles for article (PubMed ID: 23604133)
1. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Papas V; Pitsiolis T; Tsakris A; Nanas S; Roussos C
Intensive Care Med; 2013 Jul; 39(7):1253-61. PubMed ID: 23604133
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
[TBL] [Abstract][Full Text] [Related]
9. A decade of reduced gram-negative infections and mortality associated with improved isolation of burned patients.
McManus AT; Mason AD; McManus WF; Pruitt BA
Arch Surg; 1994 Dec; 129(12):1306-9. PubMed ID: 7986161
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
Maina JW; Mutua JM; Musyoki AM
BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of carbapenem-resistant gram-negative bacilli among intensive care unit (ICU) patients with no previous use of carbapenems: Indirect population impact of antimicrobial use.
Oliveira JDS; Sampaio NCFM; Leite GS; Pereira MADM; Fortaleza CMCB
Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1575-1579. PubMed ID: 35156602
[TBL] [Abstract][Full Text] [Related]
12. The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
Plantinga NL; Wittekamp BHJ; Brun-Buisson C; Bonten MJM;
Clin Microbiol Infect; 2020 Apr; 26(4):485-491. PubMed ID: 31421272
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
14. Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.
Baier C; Beck M; Panagiota V; Lueck C; Kharazipour D; Hintze SC; Bollin R; Ebadi E; Ziesing S; Eder M; Bange FC; Beutel G
Antimicrob Resist Infect Control; 2019; 8():160. PubMed ID: 31649817
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia.
Shin DH; Shin DY; Kang CK; Park S; Park J; Jun KI; Kim TS; Koh Y; Hong JS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
BMC Infect Dis; 2020 Jun; 20(1):404. PubMed ID: 32517658
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
Fang C; Zhou Z; Zhou M; Li J
Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):66. PubMed ID: 37537568
[TBL] [Abstract][Full Text] [Related]
19. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
